PR073/#425  Senaparib, a PARP inhibitor, in patients with BRCA1/2 mutated platinum sensitive recurrent ovarian cancer: subgroup analysis from Sabrina study

Xiaohua Wu; Jihong Liu; Li Wang; Zhongqiu Lin; Jing Wang; Chunyan Wang; Beihua Kong; Zhiqing Liang; Ying Cheng; Hongwu Wen; Ge Lou; Yi Huang; Ke Wang; Ruifang An; Xianqing Zhu; Huaijun Zhou; Ying Yue

doi:10.1136/ijgc-2023-IGCS.113

Article info

Featured Posters: Poster Rounds with the Professors

AS11. Ovarian cancer

PR073/#425 Senaparib, a PARP inhibitor, in patients with BRCA1/2 mutated platinum sensitive recurrent ovarian cancer: subgroup analysis from Sabrina study

Free

Authors

Xiaohua Wu Fudan University Shanghai Cancer Center, Department of Gynecologic Oncology, Shanghai, China PubMed articles Google scholar articles
Jihong Liu Sun Yat-sen University Cancer Center, Department of Gynecologic Oncology, guangzhou, China PubMed articles Google scholar articles
Li Wang Henan Cancer Hospital, Department of Gynecologic Oncology, Zhengzhou, China PubMed articles Google scholar articles
Zhongqiu Lin Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Department of Gynecologic Oncology, Guangzhou, China PubMed articles Google scholar articles
Jing Wang Hu’nan Cancer Hospital, Department of Gynecologic Oncology, Changsha, China PubMed articles Google scholar articles
Chunyan Wang Liaoning Cancer Hospital, Department of Gynecologic Oncology, Shenyang, China PubMed articles Google scholar articles
Beihua Kong Qilu hospital of Shandong University, Obstetrics and Gynecology, Jinan, Shandong province, China PubMed articles Google scholar articles
Zhiqing Liang The Southwest Hospital of AMU, Department of Gynecologic Oncology, Chongqing, China PubMed articles Google scholar articles
Ying Cheng Jilin Cancer Hospital, Department of Oncology, Changchun, China PubMed articles Google scholar articles
Hongwu Wen Peking Universtiy First Hospital, Department of Oncology, Beijing, China PubMed articles Google scholar articles
Ge Lou Harbin Medical University Cancer Hospital, Gynecological Oncology, Harbin, China PubMed articles Google scholar articles
Yi Huang Hubei Cancer Hospital, Department of Gynecologic Oncology, Wuhan, China PubMed articles Google scholar articles
Ke Wang Tianjin Cancer Hospital, Department of Gynecologic Oncology, Tianjin, China PubMed articles Google scholar articles
Ruifang An The First Affiliated Hospital of Xi’an Jiao Tong University, Department of Gynecologic Oncology, Xi’an, China PubMed articles Google scholar articles
Xianqing Zhu Zhejiang Cancer Hospital, Department of Gynecologic Oncology, Hangzhou, China PubMed articles Google scholar articles
Huaijun Zhou Nanjing Drum Tower Hospital, Department of Oncology, Nanjing, China PubMed articles Google scholar articles
Ying Yue First Hospital of Jilin University, Department of Gynecologic Oncology, Changchun, China PubMed articles Google scholar articles

Citation

Wu X, Liu J, Wang L, et al

PR073/#425 Senaparib, a PARP inhibitor, in patients with BRCA1/2 mutated platinum sensitive recurrent ovarian cancer: subgroup analysis from Sabrina study

International Journal of Gynecologic Cancer 2023;33:A73-A74.

Publication history

First published November 7, 2023.

Online issue publication

November 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password